Skip to main content
. 2013 Feb 25;2013:342561. doi: 10.1155/2013/342561

Figure 2.

Figure 2

Therapeutic effects of EWGP on obese C57BL/6 mice. (a) Body weight. (b) Diet consumption. (c) Fasting glucose levels. The mice were fasted for 12 h, and tail vein blood was used to measure the blood glucose levels. (d) Intraperitoneal glucose tolerance test (IPGTT). (e) Serum TC, TG, HDL-c, and LDL-c content. The data are shown as means ± SE. n = 7 for all groups. *P < 0.05. NS: Not significant.